The study aims to examine blood pressure indicators in men with arterial hypertension, their dependance on psoriasis, and identification of endothelium dysfunction, with vascular endothelial growth factor in combination of these diseases. The study included 168 male patients who were on outpatient treatment for stage 2 hypertension, of which 86 patients had a progressive stage of moderate severity. All patients underwent daily blood pressure monitoring and a blood test for the content of vascular endothelial growth factor. It was revealed that the level of vascular endothelial growth factor was statistically significantly higher (160.3 ± 49.9 pg/ml, p = 0.0002) in patients with a combination of hypertension and psoriasis than in those with hypertension without psoriasis. In patients with hypertension and psoriasis, statistically significantly (p < 0.05) higher variability of systolic arterial hypertension in the daytime and at night, as well as the rate of morning rise in systolic and diastolic blood pressure were noted. Also, in patients with hypertension and psoriasis, the normal daily blood pressure rhythm (dipper) was recorded more rarely (χ2 = 3.97, p = 0.046) – in 30.2 % of cases, while in patients with hypertension, the dipper daily rhythm was registered in 45 % of cases. The presence of psoriasis aggravates the course of arterial hypertension, a patient with hypertension and psoriasis requires more attention from a general physician, cardiologist and dermatovenerologist.